Literature DB >> 17576591

Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants.

A K M Tarikuz Zaman1, Satoshi Fujii, David J Schneider, Douglas J Taatjes, H Roger Lijnen, Burton E Sobel.   

Abstract

We sought to delineate mechanisms through which the lack of plasminogen activator inhibitor (PAI)-1 in the heart affects remodeling of the heart early after myocardial infarction (MI). MI was induced by coronary occlusion in 10-weeks old PAI-1 knockout (KO) and control mice. Three days after MI, systolic and diastolic function was assessed with high-resolution echocardiography, infarct size was determined biochemically and histologically and accumulation of acute inflammatory cells in zones of infarction was characterized by immunocytochemistry. PAI-1 KO mice exhibited markedly thickened diastolic left ventricular anterior walls (1.38 +/- 0.38 mm vs. 0.77 +/- 0.13 SD), more profound depression of global and regional cardiac function (19 vs. 22% fractional shortening), and greater evidence of diastolic dysfunction (average E wave amplitude = 568 vs. 675 mm/s) all of which were significant. Markedly greater extent of infarction was demonstrated biochemically and histologically in knockout mice compared with controls (76 vs. 29% of the left ventricle, P < 0.05) associated with striking hemorrhage and intense inflammation. Fibrosis normalized for infarct size was markedly reduced (0.006 vs. 0.022 microg hydroxyproline/mg dry weight). Thus, lack of PAI-1 in the heart exerted deleterious effects mediated, at least in part by increased inflammation and hemorrhage and attenuating of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576591     DOI: 10.1007/s00418-007-0300-z

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  53 in total

1.  An improved basis for enzymatic estimation of infarct size.

Authors:  R Roberts; P D Henry; B E Sobel
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

2.  The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury.

Authors:  R Renckens; J J T H Roelofs; V de Waard; S Florquin; H R Lijnen; P Carmeliet; T van der Poll
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

3.  Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease.

Authors:  J E Pérez; J B McGill; J V Santiago; K B Schechtman; A D Waggoner; J G Miller; B E Sobel
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

4.  Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.

Authors:  K Kaikita; A B Fogo; L Ma; J A Schoenhard; N J Brown; D E Vaughan
Journal:  Circulation       Date:  2001-08-14       Impact factor: 29.690

5.  Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.

Authors:  Yabing Chen; Ralph C Budd; Robert J Kelm; Burton E Sobel; David J Schneider
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05-18       Impact factor: 8.311

6.  Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.

Authors:  K Mizushige; L Yao; T Noma; H Kiyomoto; Y Yu; N Hosomi; K Ohmori; H Matsuo
Journal:  Circulation       Date:  2000-02-29       Impact factor: 29.690

7.  Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.

Authors:  Shouji Matsushima; Tomomi Ide; Mayumi Yamato; Hidenori Matsusaka; Fumiyuki Hattori; Masaki Ikeuchi; Toru Kubota; Kenji Sunagawa; Yasuhiro Hasegawa; Tatsuya Kurihara; Shinzo Oikawa; Shintaro Kinugawa; Hiroyuki Tsutsui
Journal:  Circulation       Date:  2006-04-03       Impact factor: 29.690

8.  Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery.

Authors:  J C Horrow; D F Van Riper; M D Strong; I Brodsky; J L Parmet
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

9.  Collagen remodelling in myocardia of patients with diabetes.

Authors:  M Shimizu; K Umeda; N Sugihara; H Yoshio; H Ino; R Takeda; Y Okada; I Nakanishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

10.  Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study.

Authors:  P T Donnan; D I R Boyle; J Broomhall; K Hunter; T M MacDonald; R W Newton; A D Morris
Journal:  Diabet Med       Date:  2002-06       Impact factor: 4.359

View more
  11 in total

1.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

Review 2.  Recent progress in histochemistry.

Authors:  Christian Zuber; Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2007-10-31       Impact factor: 4.304

Review 3.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

Review 4.  Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.

Authors:  Victoria A Ploplis
Journal:  Curr Drug Targets       Date:  2011-11       Impact factor: 3.465

5.  The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion.

Authors:  Christopher J French; Jeffrey L Spees; A K M Tarikuz Zaman; Douglas J Taatjes; Burton E Sobel
Journal:  FASEB J       Date:  2008-12-18       Impact factor: 5.191

6.  A novel dual staining method for identification of apoptotic cells reveals a modest apoptotic response in infarcted mouse myocardium.

Authors:  Douglas J Taatjes; Marilyn P Wadsworth; A K M Tarikuz Zaman; David J Schneider; Burton E Sobel
Journal:  Histochem Cell Biol       Date:  2007-08-08       Impact factor: 4.304

Review 7.  Circulating blood cells and extracellular vesicles in acute cardioprotection.

Authors:  Sean M Davidson; Ioanna Andreadou; Lucio Barile; Yochai Birnbaum; Hector A Cabrera-Fuentes; Michael V Cohen; James M Downey; Henrique Girao; Pasquale Pagliaro; Claudia Penna; John Pernow; Klaus T Preissner; Péter Ferdinandy
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

8.  Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription through a Pregnane X Receptor Regulated Element.

Authors:  Frederick M Stanley; Kathryn M Linder; Timothy J Cardozo
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

9.  Mdivi-1 induced acute changes in the angiogenic profile after ischemia-reperfusion injury in female mice.

Authors:  Sudhakar Veeranki; Suresh C Tyagi
Journal:  Physiol Rep       Date:  2017-06

Review 10.  Imaging aspects of cardiovascular disease at the cell and molecular level.

Authors:  Douglas J Taatjes; Marilyn P Wadsworth; Anthony S Quinn; Jacob H Rand; Edwin G Bovill; Burton E Sobel
Journal:  Histochem Cell Biol       Date:  2008-05-28       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.